· Director of the Department of Hepatobiliary and Pancreatic Surgery, Professor, and Doctoral Supervisor at the Chinese People's Liberation Army General Hospital.

· Currently serving as the Vice Chairman of the Rapid Rehabilitation Committee of a research-oriented hospital in China.

· Deputy Chairman of the Pancreatic Tumor Group of the Cross-Strait Medical Exchange Society in China.

· Standing Committee Member of the Pancreatic Disease Professional Committee of the China Medical Exchange Promotion Association.

· During his tenure, he has participated in thousands of major liver, gallbladder, and pancreatic surgeries, and has extensive experience in surgical treatment of benign and malignant diseases of the liver, gallbladder, and pancreas, as well as comprehensive treatment of advanced malignant diseases of the liver, gallbladder, and pancreas. His main research direction is surgical treatment and related clinical and basic research of hilar cholangiocarcinoma and pancreatic cancer. He is one of the experts in China who pioneered the treatment of hilar cholangiocarcinoma with portal vein arterialization and the treatment of locally advanced pancreatic cancer with nanoknife ablation.

· Led and participated in more than ten national and provincial-level research projects, and won one first prize and two second prizes for scientific and technological progress at the national and provincial levels. Has been awarded the third-class merit twice.

· Trained multiple master's and doctoral students.